{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:41:34Z","timestamp":1765294894029,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.clgc.2017.08.018","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T22:17:23Z","timestamp":1504649843000},"page":"e243-e250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Non\u2013Guideline-concordant Treatment of Testicular Cancer Is Associated With Reduced Relapse-free Survival"],"prefix":"10.1016","volume":"16","author":[{"given":"Pia","family":"Paffenholz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel Maria","family":"Heidegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Kuhr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven Heiko","family":"Loosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2017.08.018_bib1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Guidelines on testicular cancer: 2015 update","volume":"68","author":"Albers","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2017.08.018_bib2","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2017.08.018_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000049759","article-title":"EAU guidelines on testicular cancer","volume":"40","author":"Laguna","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2017.08.018_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cncr.21602","article-title":"Impact of evidence-based interdisciplinary guidelines on testis cancer management","volume":"106","author":"Schrader","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2017.08.018_bib5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.eururo.2009.10.032","article-title":"Burden or relief: do second-opinion centers influence the quality of care delivered to patients with testicular germ cell cancer?","volume":"57","author":"Schrader","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2017.08.018_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/bmj.331.7517.631","article-title":"Developing clinical guidelines: a challenge to current methods","volume":"331","author":"Raine","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.clgc.2017.08.018_bib7","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.3892\/or.2014.3153","article-title":"German second-opinion network for testicular cancer: sealing the leaky pipe between evidence and clinical practice","volume":"31","author":"Zengerling","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.clgc.2017.08.018_bib8","first-page":"684","article-title":"Adherence to National Comprehensive Cancer Network Guidelines for testicular cancer","volume":"197","author":"Wymer","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2017.08.018_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.eururo.2008.09.027","article-title":"Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection","volume":"55","author":"Heidenreich","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2017.08.018_bib10","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.ejca.2014.01.026","article-title":"Compliance with guidelines and correlation with outcome in patients with advanced germ-cell tumours","volume":"50","author":"Thibault","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2017.08.018_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clgc.2016.05.005","article-title":"Value of supraregional multidisciplinary review for the contemporary management of testicular tumors","volume":"15","author":"Purshouse","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2017.08.018_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11764-015-0468-5","article-title":"The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study","volume":"10","author":"Smith","year":"2016","journal-title":"J\u00a0Cancer Surviv"},{"key":"10.1016\/j.clgc.2017.08.018_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.genhosppsych.2015.09.001","article-title":"Anxiety and depression in long-term testicular germ cell tumor survivors","volume":"38","author":"Vehling","year":"2016","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.clgc.2017.08.018_bib14","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.urology.2014.07.054","article-title":"Patterns of performance of retroperitoneal lymph node dissections by American urologists: most retroperitoneal lymph node dissections in the United States are performed by low-volume surgeons","volume":"84","author":"Flum","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2017.08.018_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/annonc\/mdw605","article-title":"Surgical management of complex residual masses following systemic chemotherapy for metastatic testicular germ cell tumours","volume":"28","author":"Heidenreich","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2017.08.018_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00120-009-1946-z","article-title":"Testikul\u00e4re keimzelltumoren","volume":"48","author":"Schrader","year":"2009","journal-title":"Urologe"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767317302732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767317302732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:29:17Z","timestamp":1761564557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767317302732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1558767317302732"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2017.08.018","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non\u2013Guideline-concordant Treatment of Testicular Cancer Is Associated With Reduced Relapse-free Survival","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2017.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}